{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:31:22Z","timestamp":1792855882590,"version":"4.5.0"},"reference-count":125,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2507,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2008.08881.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T15:33:42Z","timestamp":1279726422000},"page":"1051-1076","source":"Crossref","is-referenced-by-count":257,"title":["Guideline for the diagnosis and management of vitiligo"],"prefix":"10.1093","volume":"159","author":[{"given":"D.J.","family":"Gawkrodger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mauri-Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,10,20]]},"reference":[{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0733-8635(05)70416-2","article-title":"Recent investigations on vitiligo vulgaris","volume":"15","author":"Nordlund","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2230.2005.01779.x","article-title":"Vitiligo presentation in adults","volume":"30","author":"Mason","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB4|cit4","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Taieb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1524-4725.1997.tb00013.x","article-title":"Utilizing the ultraviolet (UV detect) camera to enhance the appearance of photodamage and other skin conditions","volume":"23","author":"Fulton","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB7|cit7","first-page":"981","article-title":"Genetic epidemiology of vitiligo: multilocus recessivity cross-validated","volume":"55","author":"Nath","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-4362.1997.00320.x","article-title":"The progression of nonsegmental vitiligo: clinical analysis of 318 patients","volume":"36","author":"Chun","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0190-9622(95)91282-7","article-title":"An epidemiologic case-control study in a population with vitiligo","volume":"33","author":"Barona","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-4632.2004.02059.x","article-title":"What patients with vitiligo believe about their condition","volume":"43","author":"Firooz","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB12|cit12","first-page":"107","article-title":"Facial blemishes and QoL","volume":"17","author":"McMichael","year":"2004","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2133.2003.05097_9.x","article-title":"DLQI score in vitiligo and its impact on treatment outcome","volume":"148","author":"Parsad","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB16|cit16","first-page":"46","article-title":"Autologous transplantation techniques for vitiligo: how to evaluate treatment outcome","volume":"14","author":"Van Geel","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archderm.1978.01640210075025","article-title":"Personal responses of patients to vitiligo: the importance of the patient-physician interaction","volume":"114","author":"Porter","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.2005.06556.x","article-title":"A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo","volume":"153","author":"Agarwal","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02154.x","article-title":"Narrow-band UVB 311\u2003nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo","volume":"44","author":"Hartmann","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-5945-4-8","article-title":"DLQI scores in vitiligo: reliability and validity of the Persian version","volume":"4","author":"Aghaei","year":"2004","journal-title":"BMC Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalised vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: a critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2230.1996.tb00116.x","article-title":"Factors affecting responses on DLQI items amongst vitiligo sufferers","volume":"21","author":"Kent","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/08870449908407325","article-title":"Correlates of perceived stigma in vitiligo","volume":"14","author":"Kent","year":"1999","journal-title":"Psychol Health"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/1040-3590.15.4.532","article-title":"Measuring adjustment to chronic skin disorders: validation of a self-report measure","volume":"15","author":"Stangier","year":"2003","journal-title":"Psychol Assess"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.psy.0000132869.96872.b2","article-title":"Association between poorer QoL and psychiatric morbidity in patients with different dermatological conditions","volume":"66","author":"Sampogna","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2001.tb00003.x","article-title":"Psychiatric morbidity in psoriasis and vitiligo: a comparative study","volume":"28","author":"Sharma","year":"2001","journal-title":"J\u00a0Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2307\/2137152","article-title":"Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients","volume":"32","author":"Porter","year":"1991","journal-title":"J\u00a0Health Soc Behav"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB30|cit30","first-page":"425","article-title":"Different shades of meaning: illness beliefs among vitiligo sufferers","volume":"7","author":"Papadopoulos","year":"2002","journal-title":"Psychology"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modelling of narrow band UV-B phototherapy for vitiligo using a novel quantitative tool","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0\u00b71% tacrolimus vs. 0\u00b705% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1977.tb05188.x","article-title":"A double-blind trial of 0\u00b705% clobetasol propionate in the treatment of vitiligo","volume":"96","author":"Clayton","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0\u00b71 per cent betamethasone 17-valerate in isopropyl alcohol - a double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB36|cit36","first-page":"88","article-title":"Topical 0\u00b705% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-4362.1995.tb01570.x","article-title":"Comparison of 0\u00b705% clobetasol propionate cream and topical Puvasol in childhood vitiligo","volume":"34","author":"Khalid","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2002.00407.x","article-title":"Treatment of vitiligo by topical calcipotriol","volume":"16","author":"Chiaverini","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2001.04381.x","article-title":"Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo","volume":"145","author":"Ameen","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2133.2001.04286.x","article-title":"Is the efficacy of psoralen plus ultraviolet-A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study","volume":"145","author":"Ermis","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1468-3083.2003.00795.x","article-title":"Is the combination of calcipotriol and PUVA effective in vitiligo?","volume":"17","author":"Baysal","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000017991","article-title":"Combination of PUVAsol and topical calcipotriol in vitiligo","volume":"197","author":"Parsad","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D32FK376FR","article-title":"Calcipotriol and PUVA as treatment for vitiligo","volume":"9","author":"Cherif","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB45|cit45","first-page":"55","article-title":"Topical pimecrolimus in the treatment of vitiligo","volume":"17","author":"Boone","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB47|cit47","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser","volume":"42","author":"Njoo","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2230.2000.00709.x","article-title":"Management of vitiligo","volume":"25","author":"Shaffrali","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1529-8019.2001.014001029.x","article-title":"Depigmentation therapy","volume":"14","author":"Bolognia","year":"2001","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1085-5629(97)80030-2","article-title":"Vitiligo","volume":"16","author":"Le Poole","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB53|cit53","first-page":"347","article-title":"How we treat vitiligo","volume":"32","author":"Kenney","year":"1983","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2165\/00003495-199243040-00005","article-title":"Guidelines for the treatment of vitiligo","volume":"43","author":"Antoniou","year":"1992","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.01670.x","article-title":"The safety of hydroquinone","volume":"20","author":"Nordlund","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1468-3083.2005.01218.x","article-title":"Toxicology and health risks of hydroquinone in skin lightening formulations","volume":"20","author":"Kooyers","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomised double-blind trial of treatment of vitiligo. Efficacy of psoralen-UVA vs. narrowband-UVB therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1468-3083.2003.00743.x","article-title":"Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo","volume":"17","author":"Menchini","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UVA","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1067\/mjd.2002.121357","article-title":"Treatment of vitiligo with the 308-nm excimer laser: a pilot study","volume":"46","author":"Spencer","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1468-3083.2006.01547.x","article-title":"The efficacy of excimer laser (308\u2003nm) for vitiligo at different body sites","volume":"20","author":"Hofer","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2005.20.2.273","article-title":"Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study","volume":"20","author":"Hong","year":"2005","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB63|cit63","first-page":"651","article-title":"A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn","volume":"31","author":"El Mofty","year":"1948","journal-title":"J\u00a0Egypt Med Assoc"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB64|cit64","first-page":"41","article-title":"Mechanisms of psoralen photosensitization reactions","volume":"66","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ijd.1975.14.3.205","article-title":"A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo","volume":"14","author":"Sehgal","year":"1975","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000249932","article-title":"An approach to treatment of vitiligo by khellin","volume":"165","author":"Abdel-Fattah","year":"1982","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09546639509097164","article-title":"Ineffectiveness of topical khellin in photochemotherapy of vitiligo","volume":"6","author":"Procaccini","year":"1995","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000247517","article-title":"Photochemotherapy with topical khellin and sunlight in vitiligo","volume":"184","author":"Orecchia","year":"1992","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09546639809161375","article-title":"Topical photochemotherapy of vitiligo with new khellin formulation: preliminary clinical results","volume":"9","author":"Orecchia","year":"1998","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2230.2004.01462.x","article-title":"Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA","volume":"29","author":"Valkova","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB72|cit72","first-page":"191","article-title":"Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo","volume":"66","author":"Harrist","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555572305306","article-title":"PUVA treatment of vitiligo. A retrospective study of 59 patients","volume":"72","author":"Wildfang","year":"1992","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB74|cit74","first-page":"335","article-title":"Effectiveness of psoralen photochemotherapy for vitiligo","volume":"98","author":"Chuan","year":"1999","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB75|cit75","first-page":"54","article-title":"PUVA for vitiligo and skin cancer","volume":"22","author":"Westerhof","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archderm.1995.01690180114025","article-title":"Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo","volume":"131","author":"Halder","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2230.1996.tb00010.x","article-title":"Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo","volume":"21","author":"Buckley","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0190-9622(98)70247-6","article-title":"Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy","volume":"38","author":"Takeda","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2230.2004.01536.x","article-title":"Psoralen plus ultraviolet-A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin","volume":"29","author":"Abdel Naser","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1468-3083.2003.00815.x","article-title":"Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy","volume":"17","author":"Park","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/1523-1747.ep12464137","article-title":"Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment","volume":"91","author":"Stern","year":"1988","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0781.2005.00139.x","article-title":"No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalised vitiligo","volume":"21","author":"Ada","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-3083.2006.01546.x","article-title":"Combination of narrow-band UVB and topical calcipotriol for the treatment of vitiligo","volume":"20","author":"Goktas","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0781.2004.00114.x","article-title":"Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo","volume":"20","author":"Kullavanijaya","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","article-title":"Treatment of vitiligo vulgaris with narrow band UVB (311\u2003nm) for one year and the effect of addition of folic acid and vitamin B12","volume":"82","author":"Tjioe","year":"2002","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB90|cit90","first-page":"135","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patient","volume":"69","author":"Banerjee","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-4362.2000.00006.x","article-title":"Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo","volume":"39","author":"Seiter","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.1989.tb00921.x","article-title":"Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo","volume":"6","author":"Schulpis","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-4362.1979.tb01976.x","article-title":"Vitiligo treated with ACTH","volume":"18","author":"Hernandez Perez","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000251114","article-title":"Treatment of vitiligo with oral corticosteroids","volume":"153","author":"Imamura","year":"1976","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4362.1994.tb02903.x","article-title":"Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease","volume":"33","author":"Pasricha","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB98|cit98","first-page":"143","article-title":"Phenylalanine in the treatment of vitiligo","volume":"46","author":"Orecchia","year":"1992","journal-title":"Ann Ital Dermatol Clin Sper"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-4632.2005.02447.x","article-title":"Treatment of vitiligo with broadband ultraviolet B and vitamins","volume":"45","author":"Don","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB100|cit100","first-page":"536","article-title":"Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation","volume":"32","author":"Mulekar","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1346-8138.2001.tb00012.x","article-title":"Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients","volume":"28","author":"Handa","year":"2001","journal-title":"J\u00a0Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2340\/000155555577460462","article-title":"Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure","volume":"77","author":"Juhlin","year":"1997","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09546639609086883","article-title":"The failure of l-phenylalanine and UVA in the treatment of vitiligo","volume":"7","author":"Al Khawajah","year":"1996","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB105|cit105","first-page":"171","article-title":"Vitiligo. Successful treatment with dapsone","volume":"5","author":"Salafia","year":"1995","journal-title":"Chron Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB106|cit106","first-page":"247","article-title":"Comparative study of various drug regimens in vitiligo","volume":"59","author":"Patel","year":"1993","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1967.tb11461.x","article-title":"The treatment of vitiligo with psoralens and triamcinolone by mouth","volume":"79","author":"Farah","year":"1967","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB109|cit109","first-page":"308","article-title":"Vitiligo and intralesional steroids","volume":"69","author":"Vasistha","year":"1979","journal-title":"Indian J Med Res"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archderm.134.12.1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB111|cit111","first-page":"49","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00042728-200504000-00010","article-title":"Comparison of minipunch grafting versus split skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-4362.2002.01391.x","article-title":"Comparison of two surgical approaches for treating vitiligo - a preliminary study","volume":"41","author":"Ozdemir","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mjd.2003.415","article-title":"Epidermal grafting in vitiligo: influence of age, site of lesion and type of disease on outcome","volume":"49","author":"Gupta","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0190-9622(99)70490-1","article-title":"Epidermal grafts for the treatment of stable and progressive vitiligo","volume":"40","author":"Kim","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.140.10.1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"Van Geel","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00042728-200502000-00006","article-title":"Autologous epidermal cultures and narrow-band ultraviolet B in the treatment of vitiligo","volume":"31","author":"Pianigiani","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.18942","article-title":"A study of autologous melanocyte transfer in treatment of chronic stable vitiligo","volume":"71","author":"Pandya","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2003.12.013","article-title":"Treatment of vitiligo by transplantation of cultured pure melanocyte suspension - analysis of 120 cases","volume":"51","author":"Chen","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archderm.136.11.1380","article-title":"Treatment of stable vitiligo by TimedSurgery and transplantation of cultured epidermal grafts","volume":"136","author":"Guerra","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archderm.139.10.1303","article-title":"Erbium YAG laser and cultured epidermis in the surgical therapy of stable vitiligo","volume":"139","author":"Guerra","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.0007-0963.2004.05500.x","article-title":"Permanent repigmentation of piebaldism by erbium YAG laser and autologous cultured epidermis","volume":"150","author":"Guerra","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/135485099106261","article-title":"Psychological factors in cutaneous disease; an overview of research","volume":"4","author":"Papadopoulos","year":"1999","journal-title":"Psychol Health Med"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1348\/135910702169457","article-title":"Living with vitiligo: dealing with difference","volume":"7","author":"Thomson","year":"2002","journal-title":"Br J Health Psychol"},{"key":"10.1111\/j.1365-2133.2008.08881.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000083091","article-title":"Living with vitiligo: a controlled investigation into the effects of group cognitive-behavioural and person-centred therapies","volume":"5","author":"Papadopoulos","year":"2004","journal-title":"Dermatol Psychosom"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08881.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08881.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:00:20Z","timestamp":1740290420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/159\/5\/1051\/6641453"}},"subtitle":["Guideline for the diagnosis and management of vitiligo"],"short-title":[],"issued":{"date-parts":[[2008,10,20]]},"references-count":125,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08881.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,20]]}}}